HighTower Advisors LLC Reduces Stock Holdings in Integer Holdings Corporation $ITGR

HighTower Advisors LLC trimmed its position in Integer Holdings Corporation (NYSE:ITGR) by 12.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,730 shares of the medical equipment provider’s stock after selling 1,477 shares during the period. HighTower Advisors LLC’s holdings in Integer were worth $1,266,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of ITGR. AdvisorNet Financial Inc purchased a new position in Integer in the first quarter worth about $28,000. Opal Wealth Advisors LLC bought a new position in shares of Integer in the first quarter worth about $28,000. Bessemer Group Inc. raised its stake in shares of Integer by 73.1% in the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider’s stock worth $35,000 after buying an additional 125 shares during the period. Headlands Technologies LLC raised its stake in shares of Integer by 1,234.8% in the first quarter. Headlands Technologies LLC now owns 1,228 shares of the medical equipment provider’s stock worth $145,000 after buying an additional 1,136 shares during the period. Finally, Contravisory Investment Management Inc. raised its stake in shares of Integer by 103.9% in the first quarter. Contravisory Investment Management Inc. now owns 1,413 shares of the medical equipment provider’s stock worth $167,000 after buying an additional 720 shares during the period. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Stock Down 1.4%

Shares of ITGR opened at $108.9810 on Tuesday. The business’s 50 day moving average is $113.57 and its 200 day moving average is $118.67. The company has a market capitalization of $3.82 billion, a PE ratio of 48.01, a price-to-earnings-growth ratio of 0.87 and a beta of 1.02. Integer Holdings Corporation has a 12-month low of $104.93 and a 12-month high of $146.36. The company has a current ratio of 3.41, a quick ratio of 2.18 and a debt-to-equity ratio of 0.72.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.02). Integer had a net margin of 4.61% and a return on equity of 12.27%. The business had revenue of $476.00 million for the quarter, compared to the consensus estimate of $464.37 million. During the same period last year, the business posted $1.30 EPS. The firm’s revenue for the quarter was up 11.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. Research analysts expect that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Integer news, Director Martin C. Maxwell sold 8,720 shares of Integer stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total value of $1,051,283.20. Following the sale, the director owned 22,170 shares of the company’s stock, valued at $2,672,815.20. The trade was a 28.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Donald J. Spence sold 14,739 shares of Integer stock in a transaction that occurred on Wednesday, June 4th. The stock was sold at an average price of $120.38, for a total value of $1,774,280.82. Following the completion of the sale, the director directly owned 18,781 shares in the company, valued at approximately $2,260,856.78. The trade was a 43.97% decrease in their position. The disclosure for this sale can be found here. Insiders own 2.16% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Raymond James Financial decreased their price objective on Integer from $150.00 to $143.00 and set an “outperform” rating on the stock in a research note on Friday, July 25th. Wells Fargo & Company decreased their price objective on Integer from $152.00 to $132.00 and set an “overweight” rating on the stock in a research note on Friday, July 25th. Citigroup raised Integer from a “hold” rating to a “strong-buy” rating and raised their price objective for the stock from $133.00 to $140.00 in a research note on Thursday, May 22nd. Wall Street Zen raised Integer from a “sell” rating to a “hold” rating in a research note on Monday, May 19th. Finally, Truist Financial decreased their target price on Integer from $145.00 to $137.00 and set a “buy” rating on the stock in a research note on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $140.25.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.